Related Experiment Video
Updated: May 2, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Culprit vessel only versus multivessel percutaneous coronary intervention in patients presenting with ST-segment
Dongfeng Zhang1, Xiantao Song1, Shuzheng Lv1
1Department of Cardiology, Capital Medical University affiliated Beijing Anzhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Disease, Beijing, China.
Insights
For ST-elevation myocardial infarction (STEMI) with multivessel disease (MVD), treating only the culprit artery during percutaneous coronary intervention (PCI) is linked to better outcomes than multivessel PCI (MV-PCI). This approach reduces mortality and renal dysfunction risk.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Research
Background:
- Optimal treatment strategy for ST-segment elevation myocardial infarction (STEMI) patients with multivessel disease (MVD) undergoing primary percutaneous coronary intervention (PCI) remains unclear.
- Multivessel disease (MVD) is common in STEMI patients, necessitating careful consideration of intervention scope.
Purpose of the Study:
- To compare the clinical outcomes of culprit vessel only percutaneous coronary intervention (culprit PCI) versus multivessel percutaneous coronary intervention (MV-PCI) in STEMI patients with MVD.
- To provide evidence-based recommendations for PCI strategy in STEMI with MVD through a comprehensive meta-analysis.
Main Methods:
- Systematic literature search of major databases (PubMed, Elsevier, Embase, CNKI) for relevant randomized and non-randomized studies.
- Meta-analysis of included studies using Review Manager 5.1 to compare outcomes between culprit PCI and MV-PCI strategies.
- Inclusion of data from 4 randomized and 14 non-randomized studies, encompassing 39,390 patients.
Main Results:
- Multivessel PCI (MV-PCI) was associated with increased short-term and long-term mortality compared to culprit vessel only PCI (culprit PCI).
- MV-PCI also showed a higher risk of renal dysfunction.
- Conversely, MV-PCI demonstrated a reduced incidence of revascularization compared to culprit PCI.
Conclusions:
- The findings support current guidelines recommending against treating non-culprit vessels during the index procedure for STEMI patients with MVD.
- Culprit vessel only PCI appears to be a safer strategy regarding mortality and renal outcomes in this patient population.
Background:
The best strategy for ST-segment elevation myocardial infarction (STEMI) patients with multivessel disease (MVD), who underwent primary percutaneous coronary intervention (PCI) in the acute phase, is not well established.
Objectives:
Our goal was to conduct a meta-analysis comparing culprit vessel only percutaneous coronary intervention (culprit PCI) with multivessel percutaneous coronary intervention (MV-PCI) for treatment of patients with STEMI and MVD.
Methods:
Pubmed, Elsevier, Embase, and China National Knowledge Infrastructure (CNKI) databases were systematically searched for randomized and nonrandomized studies comparing culprit PCI and MV-PCI strategies during the index procedure. A meta-analysis was performed using Review Manager 5.1 (Cochrane Center, Denmark).
Results:
Four randomized and fourteen nonrandomized studies involving 39,390 patients were included. MV-PCI strategy is associated with an increased short-term mortality (OR: 0.50, 95% CI: 0.32 to 0.77, p = 0.002), long-term mortality (OR: 0.52, 95% CI: 0.36 to 0.74, p<0.001), and risk of renal dysfunction (OR: 0.77, 95% CI: 0.61 to 0.97, p = 0.03) compared with culprit PCI strategy, while it reduced the incidence of revascularization (OR: 2.65, 95% CI: 1.80 to 3.90, p<0.001).
Conclusions:
This meta-analysis supports current guidelines which indicate that the non-culprit vessel should not be treated during the index procedure.
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
06:39Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
Published on: February 18, 2020
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care